Daewon Chemical대원화성
024890 · KOSPI · ₩024890 · 대원화성
₩1,462▼ ₩23 (1.55%)End-of-day · Oct 30, 2026 · End-of-day prices.
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | ₩126B | ₩126B | ₩122B | ₩147B | ₩113B |
| Cost of sales | ₩106B | ₩105B | ₩108B | ₩130B | ₩100B |
| Gross profit | ₩21B | ₩21B | ₩14B | ₩17B | ₩14B |
| Operating income | ₩871M | −₩6.1B | −₩6.4B | −₩7.4B | −₩8.4B |
| Net income | ₩3.5B | −₩12B | −₩9.7B | −₩9.6B | −₩7B |
| Net income to shareholders | ₩3.5B | −₩12B | −₩9.7B | −₩9.6B | −₩7B |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Total assets | ₩148B | ₩153B | ₩138B | ₩131B | ₩136B |
| Current assets | ₩76B | ₩83B | ₩69B | ₩74B | ₩72B |
| Cash and equivalents | ₩5.7B | ₩5.3B | ₩13B | ₩11B | ₩13B |
| Total liabilities | ₩104B | ₩111B | ₩86B | ₩68B | ₩65B |
| Current liabilities | ₩94B | ₩97B | ₩69B | ₩63B | ₩57B |
| Borrowings | ₩67B | ₩69B | ₩58B | ₩49B | ₩45B |
| Total equity | ₩45B | ₩42B | ₩53B | ₩62B | ₩71B |
| Shareholders' equity | ₩45B | ₩42B | ₩53B | ₩62B | ₩71B |
Cash flow
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash from operations | ₩3.5B | −₩14B | −₩298M | −₩6.8B | −₩7.4B |
| Capital spending | ₩1.1B | ₩2.4B | ₩5.3B | ₩1.2B | ₩915M |
| Free cash flow | ₩2.4B | −₩16B | −₩5.6B | −₩7.9B | −₩8.3B |
| Dividends paid | ₩6.3M | — | ₩0 | ₩0 | ₩409M |
Consolidated where available. Amounts in won.
Also known as: Daewon Chemical / 대원화성 / 024890 / KRX:024890
Source: KRX statistical information